Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more
VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
VANCOUVER, British Columbia, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
VANCOUVER, British Columbia, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) (the “Company”), a clinical-stage biotechnology company developing a diverse pipeline of novel...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.82 | 6.70482420278 | 12.23 | 13.14 | 12.089 | 750363 | 12.56158473 | CS |
4 | 1.81 | 16.103202847 | 11.24 | 13.14 | 11.18 | 774645 | 11.91023854 | CS |
12 | 4.52 | 52.9894490035 | 8.53 | 13.14 | 8.32 | 732079 | 10.7205194 | CS |
26 | 2.52 | 23.9316239316 | 10.53 | 13.14 | 7.97 | 660907 | 9.87146264 | CS |
52 | 6.13 | 88.5838150289 | 6.92 | 13.14 | 6.015 | 573585 | 9.76232449 | CS |
156 | 6.67 | 104.545454545 | 6.38 | 13.14 | 6.015 | 635706 | 9.07295423 | CS |
260 | 6.67 | 104.545454545 | 6.38 | 13.14 | 6.015 | 635706 | 9.07295423 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.